These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7698870)
1. Remission of secondary Raynaud phenomenon using intra-arterial prostaglandin E1 infusion. A case report. Seemann J; Scholz J; Sielwicz M Int Orthop; 1994; 18(6):372-4. PubMed ID: 7698870 [TBL] [Abstract][Full Text] [Related]
2. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon. DiGiovanni RL; Littlefield JM; Good RG J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544 [No Abstract] [Full Text] [Related]
3. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions. Langevitz P; Buskila D; Lee P; Urowitz MB J Rheumatol; 1989 Nov; 16(11):1433-5. PubMed ID: 2600942 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1. Weiss T; Eckstein H; Weiss C; Diehm C Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509 [TBL] [Abstract][Full Text] [Related]
5. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon. Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851 [TBL] [Abstract][Full Text] [Related]
6. [Experience with the therapy of acute finger ischemia by high-dose intra-arterial infusion of PGE1 through a surgically introduced catheter]. Altstaedt HO Chirurg; 1999 Oct; 70(10):1144-8. PubMed ID: 10550345 [TBL] [Abstract][Full Text] [Related]
7. [Atypical HHS-syndrome--a rare differential diagnosis of circulatory disorders of the hand]. Müller-Mai C; Voigt C; Smektala R; König M Handchir Mikrochir Plast Chir; 2004 Feb; 36(1):59-63. PubMed ID: 15083393 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case. Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin infusion therapy for intermittent digital ischemia in a patient with mixed connective tissue disease. Case report and review of the literature. Cohen LE; Faske I; Fenske NA; Greist MA J Am Acad Dermatol; 1989 May; 20(5 Pt 2):893-7. PubMed ID: 2654223 [TBL] [Abstract][Full Text] [Related]
10. [Critical ischemia of the extremities caused by ergotism. Treatment with intra-arterial prostaglandin E1 infusion]. Horstmann R; Daum H; Heller M; Schröder A Dtsch Med Wochenschr; 1993 Jul; 118(29-30):1067-71. PubMed ID: 8330508 [TBL] [Abstract][Full Text] [Related]
11. Raynaud's disease in childhood with radiological features. Shono T; Okadome K; Naritomi G; Suita S Br J Radiol; 1990 May; 63(749):364-6. PubMed ID: 2379063 [No Abstract] [Full Text] [Related]
12. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease]. Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905 [TBL] [Abstract][Full Text] [Related]
13. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease]. Rudofsky G Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330 [No Abstract] [Full Text] [Related]
14. Successful treatment of Raynaud's phenomenon with limaprost, an oral prostaglandin E1 analogue. Tsukamoto H; Nagasawa K Br J Rheumatol; 1991 Aug; 30(4):317. PubMed ID: 1863837 [No Abstract] [Full Text] [Related]